RGS7BP

RGS7BP (R7BP) is a palmitoylated, SNARE-related neuronal membrane anchor that assembles heterotrimeric complexes with all four R7-family RGS proteins (RGS6, RGS7, RGS9, RGS11) and Gβ5, thereby controlling the subcellular localization, proteolytic stability, and signaling efficacy of these GTPase-accelerating proteins at postsynaptic densities (PMID:15632198, PMID:16574655, PMID:18094251). Palmitoylation of a C-terminal polybasic/cysteine motif targets R7BP–RGS–Gβ5 complexes to the plasma membrane, where they accelerate Gαi/o GTP hydrolysis to attenuate GPCR-evoked GIRK channel activation, while depalmitoylation redirects the complexes to the nucleus; cytoplasmic complexes are functionally inert (PMID:15897264, PMID:16867977). The crystal structure of the RGS7–Gβ5–R7BP trimer reveals long-range allosteric modulation across multiple synergistic intermolecular interfaces (PMID:30540250). Activity-dependent calcium entry dynamically remodels R7BP partner identity, uncoupling RGS9-2 for degradation and recruiting RGS7 to the membrane, thereby tuning striatal GPCR signaling relevant to motor coordination, opioid sensitivity, and itch sensation (PMID:19332565, PMID:20043004, PMID:28134655).

1. 2005 High

   Identification of R7BP as a novel binding partner of all four R7-family RGS proteins resolved how these cytosolic GTPase-accelerating proteins could be anchored at the membrane, analogous to R9AP in photoreceptors.

   Evidence Co-immunoprecipitation from brain and in vitro reconstitution with recombinant DEP domains

   PMID:15632198

   Open questions at the time

   • Stoichiometry of the complex was not determined
   • Relative affinity for different R7 RGS family members was unknown
   • In vivo functional consequence of R7BP loss was not tested
2. 2005 High

   Demonstrating that palmitoylation of R7BP controls plasma membrane versus nuclear localization of RGS complexes, and that only membrane-targeted complexes enhance GIRK channel regulation, established palmitoylation as the functional switch governing R7BP signaling output.

   Evidence Palmitoylation assays, subcellular fractionation, live-cell imaging, and GIRK electrophysiology

   PMID:15897264

   Open questions at the time

   • Identity of the palmitoyl acyltransferase was not determined
   • Nuclear function, if any, of depalmitoylated complexes was unexplored
3. 2006 High

   Mapping the C-terminal polybasic motif and dual palmitoylation sites as synergistic determinants of membrane targeting and nuclear import resolved how a short peptide segment encodes two opposing localization signals.

   Evidence Site-directed mutagenesis combined with subcellular fractionation and GIRK electrophysiology

   PMID:16574655 PMID:16867977

   Open questions at the time

   • Whether nuclear localization has signaling function remained unknown
   • Regulation of palmitoylation cycling was not addressed
4. 2006 High

   Showing that R7BP stabilizes RGS9-2 by reducing its degradation rate established a proteostatic role beyond simple membrane anchoring, explaining why RGS protein levels depend on R7BP expression.

   Evidence Co-expression degradation kinetics and lentiviral RNAi knockdown in striatal neurons with DEP/R7H domain mapping

   PMID:17158100

   Open questions at the time

   • Identity of the degradation pathway was not yet pinpointed
   • Whether stabilization applied equally to all R7 family members was untested
5. 2007 High

   Identifying lysosomal cysteine proteases as the constitutive degradation pathway blocked by R7BP, and showing postnatal co-development of R7BP-RGS9-2 targeting with synaptic maturation, established R7BP as a developmentally regulated protector of synaptic RGS complexes.

   Evidence Protease inhibitor studies, immunoelectron microscopy, and developmental expression analysis

   PMID:18094251

   Open questions at the time

   • Specific cysteine protease identity was not determined
   • Mechanism of shielding from proteases was not structurally resolved
6. 2008 Medium

   Demonstrating that RGS7/Gβ5 can reach ON-bipolar cell dendrites independently of R7BP revealed that R7BP is not universally required for subcellular targeting, defining a context-dependent role.

   Evidence Immunofluorescence in R7BP knockout mouse retina

   PMID:18842904

   Open questions at the time

   • Alternative targeting mechanism for RGS7 in ON-bipolar cells was not identified
   • Functional consequence of R7BP loss in ON-bipolar cells was not fully assessed
7. 2009 High

   Discovery that activity-dependent calcium entry uncouples RGS9-2 from R7BP and recruits RGS7 in its place established a dynamic, stimulus-driven remodeling mechanism that tunes which R7 RGS protein operates at the synapse.

   Evidence Co-immunoprecipitation, subcellular fractionation, calcium manipulation, and immunoelectron microscopy in striatal neurons

   PMID:19332565

   Open questions at the time

   • Calcium sensor mediating the switch was not identified
   • Whether this mechanism operates outside the striatum was unknown
8. 2009 Medium

   R7BP knockout mice exhibited motor coordination deficits and enhanced morphine sensitivity, while striatal RGS7 knockdown affected cocaine-induced locomotor sensitization, linking R7BP-organized signaling modules to specific behavioral outputs.

   Evidence R7BP knockout and striatum-specific lentiviral knockdown with behavioral assays

   PMID:20043004

   Open questions at the time

   • Cell-type-specific contributions within striatum were not resolved
   • Direct electrophysiological mechanism underlying behavioral phenotypes was not determined
9. 2014 High

   Demonstrating that RGS7/R7BP shapes the dynamic range of GABAB-GIRK signaling in hippocampal neurons, controlling neuronal excitability, inhibitory synaptic plasticity, and memory, extended R7BP function beyond the striatum to cognitive circuits.

   Evidence RGS7 knockout mice with electrophysiology and behavioral memory assays

   PMID:24755289

   Open questions at the time

   • Specific contribution of R7BP versus RGS7 in hippocampal phenotypes was not fully dissected
   • Whether R7BP levels are regulated by hippocampal plasticity was not tested
10. 2017 Medium

    Genetic epistasis showing R7BP knockout reduces itch responses and that this is rescued by kappa-opioid receptor co-deletion placed R7BP upstream of opioid-mediated pruriceptive signaling, expanding its physiological roles to somatosensation.

    Evidence R7BP knockout and R7BP/Oprk1 double knockout mice with pruriceptive behavioral assays

    PMID:28134655

    Open questions at the time

    • Which R7 RGS protein mediates the itch phenotype was not determined
    • Spinal versus peripheral circuit contributions were not dissected
11. 2018 High

    The crystal structure of the RGS7–Gβ5–R7BP trimer revealed long-range allosteric changes and multiple synergistic intermolecular interfaces, providing the first atomic-resolution framework for understanding how R7BP modulates RGS catalytic activity.

    Evidence X-ray crystallography, molecular dynamics simulation, and hydrogen-deuterium exchange mass spectrometry

    PMID:30540250

    Open questions at the time

    • Structure of R7BP complexed with other R7 family members was not solved
    • How palmitoylation alters the structural conformation was not captured
12. 2019 Medium

    Cross-linking mass spectrometry mapped R7BP–RGS7 interaction interfaces and enabled design of dominant-negative R7BP inhibitors, demonstrating that the complex can be pharmacologically disrupted.

    Evidence Cross-linking mass spectrometry, surface plasmon resonance, and dominant-negative construct validation

    PMID:31531399

    Open questions at the time

    • In vivo efficacy of dominant-negative constructs was not tested
    • Selectivity among R7 RGS family members was not assessed

• Key unresolved questions include the identity of the palmitoyl acyltransferase and thioesterase that cycle R7BP palmitoylation, the calcium sensor mediating activity-dependent partner switching, whether nuclear R7BP complexes have signaling functions, and whether R7BP dysfunction contributes to human neurological disease.
• Palmitoylation enzyme identity unknown
• Calcium sensor for RGS partner switching unidentified
• No human genetic disease association established